EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY 4.0

Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism

Christopher Kobylecki iD, Viorica Chelban iD, Yee Yen Goh, Emilia Michou iD, Riona Fumi, Marte Theilmann Jensen, Rahema Mohammad, Alyssa Costantini, Nirosen Vijiaratnam, Samantha Pavey, Nicola Pavese iD, P Nigel Leigh and 5 more

European Journal of Neurology · 2024

DOI: 10.1111/ene.16258 ↗

At a glance

Kohortenstudie in European Journal of Neurology, 2024. Written by Christopher Kobylecki and 16 co-authors. Institution: Division of Neuroscience, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK. Major MEDLINE topics: Gastrostomy, Supranuclear Palsy, Progressive, Multiple System Atrophy, Parkinsonian Disorders. Cited 5 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Research Council, Multiple System Atrophy Trust, PSP Association.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) show a high prevalence and rapid progression of dysphagia, which is associated with reduced survival. Despite this, the evidence base for gastrostomy is poor, and the optimal frequency and outcomes of this intervention are not known. We aimed to characterise the prevalence and outcomes of gastrostomy in patients with these three atypical parkinsonian disorders.

Method

We analysed data from the natural history and longitudinal cohorts of the PROSPECT‐M‐UK study with up to 60 months of follow‐up from baseline. Survival post‐gastrostomy was analysed using Kaplan–Meier survival curves.

Results

In a total of 339 patients (mean age at symptom onset 63.3 years, mean symptom duration at baseline 4.6 years), dysphagia was present in >50% across all disease groups at baseline and showed rapid progression during follow‐up. Gastrostomy was recorded as recommended in 44 (13%) and performed in 21 (6.2%; MSA 7, PSP 11, CBS 3) of the total study population. Median survival post‐gastrostomy was 24 months compared with 12 months where gastrostomy was recommended but not done ( p = 0.008). However, this was not significant when correcting for age and duration of symptoms at the time of procedure or recommendation.

Conclusions

Gastrostomy was performed relatively infrequently in this cohort despite the high prevalence of dysphagia. Survival post‐gastrostomy was longer than previously reported, but further data on other outcomes and clinician and patient perspectives would help to guide use of this intervention in MSA, PSP and CBS.

Subjects

MeSH terms (MEDLINE)

GastrostomySupranuclear Palsy, ProgressiveMultiple System AtrophyParkinsonian DisordersDeglutition DisordersHumansMiddle AgedMaleFemaleAgedLongitudinal StudiesCohort StudiesTreatment OutcomeDisease Progression

Author keywords

dysphagiagastrostomymultiple system atrophyparkinsonismprogressive supranuclear palsy

Authors and institutions

  • Division of Neuroscience, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Department of Neurology, Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust, Salford, UK.
  • Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, UK.
  • Neurobiology and Medical Genetics Laboratory, "Nicolae Testemitanu" State University of Medicine and Pharmacy, Chisinau, Republic of Moldova.
  • Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.
  • Department of Speech and Language Therapy, School of Health Rehabilitation Sciences, University of Patras, Patras, Greece.

ORCID profiles: Christopher Kobylecki, Viorica Chelban, Emilia Michou, Nicola Pavese

Funding

  • Medical Research Council
  • Multiple System Atrophy Trust
  • PSP Association

Cite

APA

Kobylecki, C., Chelban, V., Goh, Y. Y., Michou, E., Fumi, R., Theilmann Jensen, M., Mohammad, R., Costantini, A., Vijiaratnam, N., Pavey, S., Pavese, N., Leigh, P. N., Rowe, J. B., Hu, M. T., Church, A., Morris, H. R., & Houlden, H. (2024). Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism. European Journal of Neurology. https://doi.org/10.1111/ene.16258

Vancouver

Kobylecki C, Chelban V, Goh YY, Michou E, Fumi R, Theilmann Jensen M, et al. Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism. European Journal of Neurology. 2024. doi:10.1111/ene.16258

BibTeX
@article{Kobylecki2024,
  author = {Kobylecki, Christopher and Chelban, Viorica and Goh, Yee Yen and Michou, Emilia and Fumi, Riona and Theilmann Jensen, Marte and Mohammad, Rahema and Costantini, Alyssa and Vijiaratnam, Nirosen and Pavey, Samantha and Pavese, Nicola and Leigh, P Nigel and Rowe, James B and Hu, Michele T and Church, Alistair and Morris, Huw R and Houlden, Henry},
  title = {Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16258}
}
Start for free →